Kite inopedzisa kutora Tmunity

Giriyedhi-Sayenzi dzoupenyu

Share This Post

Press Release

Kukadzi 2023: - Kite, Kambani yeGiriyedhi (NASDAQ: GILD), nhasi yakazivisa kupedzwa kweiyo yakamboziviswa kutengeserana kuwana Tmunity Therapeutics (Tmunity), yekiriniki-nhanho, yakazvimirira biotech kambani yakatarisana nechizvarwa chinotevera cheCAR T-kurapa uye matekinoroji.

Kutorwa kweTmunity kunopindirana neKite iripo mu-house cell therapy yekutsvagisa kugona nekuwedzera mamwe mapombi emidziyo, kugona kwepuratifomu, uye hurongwa hwekutsvagisa uye chibvumirano cherezinesi neYunivhesiti yePennsylvania (Penn). Ichapa Kite mukana wekuwana pre-kiriniki uye zvirongwa zvekiriniki, kusanganisira 'yezvombo' CAR T tekinoroji chikuva, iyo inogona kushandiswa kune akasiyana siyana eCAR T's kusimudzira anti-bundu chiitiko, pamwe nekukurumidza kugadzira maitiro. Pamusoro pezvo, sechikamu chekutora, vatangi veTmunity, vanoramba vari mumabasa avo kuPenn, vanozopawo masevhisi ekupa mazano kuKite sevapi vapi vezano vesainzi.

Yunivhesiti yePennsylvania Hukama

The University of Pennsylvania's Carl June, Bruce Levine, James Riley, Anne Chew vaive munhu wega wega equity muTmunity uye vava kubhadharwa vapi vemazano vesainzi kuKite. Penn aivewo mutengi muTmunity. Penn akawana mari yekutsvagisa yakatsigirwa kubva kuTmunity, uye parizvino achawana mari yekutsvagisa kubva kuKite zvichitevera kupera kwanhasi. Sevagadziri vemimwe michina ine rezinesi, Dr. June, Levine, Riley, uye Chew, pamwe naPenn, vanogona kuwana mamwe mabhenefiti emari pasi perezinesi mune ramangwana.

About Kite

Kite, Kambani yeGiriyedhi, ikambani yepasi rose biopharmaceutical yakavakirwa muSanta Monica, California, yakatarisana nesero kurapwa kurapa uye kurapa cancer. Semutungamiri wepasi rose cell therapy, Kite akarapa varwere vakawanda CAR T-cell kurapa than any other company. Kite has the largest in-house cell therapy manufacturing network in the world, spanning process development, vector manufacturing, kliniki yekuedzwa supply, and commercial product manufacturing. 

NezveGiriyedhi Sayenzi

Giriyedhi Sayenzi, Inc. ikambani yebiopharmaceutical yakatsvaga uye yakawana budiriro mukurapa kweanopfuura makumi matatu emakore, nechinangwa chekugadzira nyika ine hutano kune vese vanhu. Kambani iyi yakazvipira kusimudzira mishonga yekudzivirira nekurapa zvirwere zvinouraya, zvinosanganisira HIV, viral hepatitis negomarara. Gilead inoshanda munyika dzinopfuura 35 munyika yose, ine dzimbahwe muFoster City, California. Sainzi yeGiriyedhi yakawana Kite muna 2017.

Mashoko Anotarira Mberi kuGilead

Kuburitswa kwenhau uku kunosanganisira "zvirevo zvinotarisa kumberi" mukati mezvinoreva iyo Private Securities Litigation Reform Act ye1995 iyo iri pasi penjodzi, kusava nechokwadi, uye zvimwe zvinhu, kusanganisira njodzi yekuti Giriyedhi neKite vangasaziva mabhenefiti anotarisirwa ekutengeserana uku. , kusanganisira kugona kweKite kufambisira mberi zvinhu zvakatorwa kubva kuTmunity kuburikidza nehurongwa hwekutsvagisa uye chibvumirano cherezinesi naPenn kana neimwe nzira; matambudziko kana mari isingatarisirwi ine chekuita nekutora uye kubatanidzwa; migumisiro inogona kuitika yezvose zvataurwa pamusoro pemihoro yeGiriyedhi neKite; uye chero fungidziro dziri pasi pezvipi zvataurwa pamusoro apa. Idzi nedzimwe njodzi, kusava nechokwadi, uye zvimwe zvinhu zvinotsanangurwa zvakadzama muGiriyedhi Quarterly Report paFomu 10-Q yekota yakapera September 30, 2022, sezvakaiswa kuUS Securities and Exchange Commission. Njodzi idzi, kusavimbika, uye zvimwe zvinhu zvinogona kuita kuti mhedzisiro chaiyo isiyane kubva kune inotaurwa nezvayo muzvirevo zvinotarisisa. Zvese zvirevo kunze kwezvirevo zvechokwadi chenhoroondo zvirevo zvinogona kunzi zvirevo zvinomirira mberi. Muverengi anonyeverwa kuti chero zvirevo zvekumberi zvakadaro hazvisi vimbiso yekuita ramangwana uye zvinosanganisira njodzi uye kusava nechokwadi, uye anoyambirwa kuti asaise chivimbo chisina kufanira pane izvi zvirevo zvinotarisisa. Zvose zvinotarisisa zviri mberi zvakabva paruzivo rwuripo kuGiriyedhi neKite, uye Giriyedhi neKite havafungi kuti vanosungirwa kuti vagadzirise zvirevo zvakadaro.

Subscribe To Newsletter Vedu

Wana zvigadziriso uye usambopotsa blog kubva kuCancerfax

Zvimwe Kuti Uongorore

Kurapa Kwemasero eCAR T kunoitwa nevanhu: Kubudirira Uye Zvinetso
CAR T-Cell kurapa

Kurapa Kwemasero eCAR T: Kubudirira uye Zvinetso

Human-based CAR T-cell therapy inosandura kurapwa kwegomarara nekugadzirisa magene masero emuviri emurwere kuti anange nekuparadza maseru egomarara. Nekushandisa simba rekudzivirira kwemuviri, marapirwo aya anopa marapiro ane simba uye emunhu ane mukana wekuregererwa kwenguva refu mumhando dzakasiyana dzegomarara.

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa
CAR T-Cell kurapa

Kunzwisisa Cytokine Release Syndrome: Zvinokonzera, Zviratidzo, uye Kurapa

Cytokine Release Syndrome (CRS) is immune system reaction inowanzo kukonzerwa nemamwe marapirwo senge immunotherapy kana CAR-T cell therapy. Zvinosanganisira kuburitswa kwakanyanya kwemacytokines, zvichikonzera zviratidzo kubva pafivha uye kuneta kusvika kune zvinogona kuuraya hupenyu sekukuvadzwa kwenhengo. Kutungamira kunoda kunyatsotarisisa uye nzira dzekupindira.

Kuda rubatsiro? Chikwata chedu chakagadzirira kukubatsira.

Tinoshuvira kupora nekukurumidza kwemudiwa wako uye padyo neuyo.

Kutanga kutaura
Tiri paIndaneti! Taura Nesu!
Skena kodhi
Mhoro,

Kugamuchirwa kuCancerFax!

CancerFax ipuratifomu yekupayona yakatsaurirwa kubatanidza vanhu vakatarisana negomarara repamberi nekurapa kwesero seCAR T-Cell therapy, TIL kurapwa, uye miedzo yekiriniki pasi rese.

Tizivise zvatinogona kukuitira.

1) Kurapwa kwegomarara kunze kwenyika?
2) CAR T-Cell therapy
3) Mushonga wegomarara
4) Online vhidhiyo kubvunza
5) Proton kurapwa